Corrigendum: THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors. uri icon

Overview

publication date

  • February 20, 2017

Identity

PubMed Central ID

  • PMC5321718

Scopus Document Identifier

  • 85055618183

Digital Object Identifier (DOI)

  • 10.1038/ncomms14747

PubMed ID

  • 28218232

Additional Document Info

volume

  • 8